Skip to main content
Erschienen in: Archives of Dermatological Research 5-6/2007

01.08.2007 | Original Paper

Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone

verfasst von: Tomasz Wasyłyszyn, Wojciech Kozłowski, Stanisław Leopold Zabielski

Erschienen in: Archives of Dermatological Research | Ausgabe 5-6/2007

Einloggen, um Zugang zu erhalten

Abstract

For many years, the role of T lymphocytes was hypothesized as being a major factor responsible for hair loss in alopecia areata (a.a.). While numerous lymphocytic populations were found around hair bulbs, changes in their distribution patterns in the skin during the course and recovery of the disease remain unknown. In the present study, distribution of CD8 lymphocytes in biopsies obtained from a.a. patients was measured before and during treatment using diphencyprone (DCP). Results show about a 600% increase in the number of CD8 lymphocytes under the epithelium and about a 250% increase around hair bulbs and other epidermal appendages during the study. These results were more significant in a group, which had good clinical response to the treatment. No change in the quantity of CD8 lymphocytes was observed around the blood vessels. Since CD8 lymphocytes are considered to be directly involved in the hair destruction process in a.a., their increased number around hair bulbs followed by hair regrowth may suggest that during DCP treatment they regain normal reactivity to hair antigens.
Literatur
1.
Zurück zum Zitat Baadsgaard O, Lindskov R, Clemmensen J (1987) In situ lymphocyte subsets in alopecia areata before and during treatment with a contact allergen. Clin Exp Dermatol 12(4):260–264PubMedCrossRef Baadsgaard O, Lindskov R, Clemmensen J (1987) In situ lymphocyte subsets in alopecia areata before and during treatment with a contact allergen. Clin Exp Dermatol 12(4):260–264PubMedCrossRef
2.
Zurück zum Zitat Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y (2000) Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114(1):112–116PubMedCrossRef Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y (2000) Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114(1):112–116PubMedCrossRef
3.
Zurück zum Zitat Brocker EB, Echternacht-Happle K, Hamm H, Happle R (1987) Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 88(5):564–568PubMedCrossRef Brocker EB, Echternacht-Happle K, Hamm H, Happle R (1987) Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 88(5):564–568PubMedCrossRef
4.
Zurück zum Zitat Freyschmidt-Paul P, Hamm H, Happle R, Hoffmann R (1999) Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone. Eur J Dermatol 9(2):111–114PubMed Freyschmidt-Paul P, Hamm H, Happle R, Hoffmann R (1999) Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone. Eur J Dermatol 9(2):111–114PubMed
5.
Zurück zum Zitat Freyschmidt Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R (1999) Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 113(1):61–68PubMedCrossRef Freyschmidt Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R (1999) Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 113(1):61–68PubMedCrossRef
6.
Zurück zum Zitat Freyschmidt-Paul P, Ziegler A, McElwee KJ, Happle R, Kissling S, Sundberg JP, Hoffmann R (2001) Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus). Eur J Dermatol 11(5):405–409PubMed Freyschmidt-Paul P, Ziegler A, McElwee KJ, Happle R, Kissling S, Sundberg JP, Hoffmann R (2001) Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus). Eur J Dermatol 11(5):405–409PubMed
7.
Zurück zum Zitat Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin D (2000) Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Eur J Dermatol 10(6):443–450PubMed Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin D (2000) Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Eur J Dermatol 10(6):443–450PubMed
8.
Zurück zum Zitat Ghersetich I, Campanile G, Lotti T (1996) Alopecia areata:immunihistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors. Int J Dermatol 35(1):28–33PubMedCrossRef Ghersetich I, Campanile G, Lotti T (1996) Alopecia areata:immunihistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors. Int J Dermatol 35(1):28–33PubMedCrossRef
9.
Zurück zum Zitat Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101(1):62–67PubMedCrossRef Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101(1):62–67PubMedCrossRef
10.
Zurück zum Zitat Happle R, Klein HM, Macher E (1986) Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 278(3):214–218PubMedCrossRef Happle R, Klein HM, Macher E (1986) Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 278(3):214–218PubMedCrossRef
11.
Zurück zum Zitat Hoting E, Boehm A (1992) Therapy of alopecia areata with diphencyprone. Br J Dermatol 127(6):625–629PubMedCrossRef Hoting E, Boehm A (1992) Therapy of alopecia areata with diphencyprone. Br J Dermatol 127(6):625–629PubMedCrossRef
12.
Zurück zum Zitat Jabłońska S (1983) (red): Łysienie plackowate in Choroby Skóry t. II, Warszawa, PZWL 977–980 Jabłońska S (1983) (red): Łysienie plackowate in Choroby Skóry t. II, Warszawa, PZWL 977–980
13.
Zurück zum Zitat Konig A, Happle R, Hoffman R (1997) IFN-gamma induced HLA DR but not ICAM 1 expresion on cultured dermal papilla cells is downregulated by TNF-alpha. Arch Dermatol Res 289:466–470PubMedCrossRef Konig A, Happle R, Hoffman R (1997) IFN-gamma induced HLA DR but not ICAM 1 expresion on cultured dermal papilla cells is downregulated by TNF-alpha. Arch Dermatol Res 289:466–470PubMedCrossRef
14.
Zurück zum Zitat McElwee KJ, Boggess D, King LE Jr, Sundberg JP (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111(5):797–803PubMedCrossRef McElwee KJ, Boggess D, King LE Jr, Sundberg JP (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111(5):797–803PubMedCrossRef
15.
Zurück zum Zitat McElwee KJ, Spiers EM, Oliver RF (1996) In vivo depletion of CD8 + T cells restores hair growth in the DEBR modelfor alopecia areata. Br J Dermatol 135(2):211–217PubMedCrossRef McElwee KJ, Spiers EM, Oliver RF (1996) In vivo depletion of CD8 + T cells restores hair growth in the DEBR modelfor alopecia areata. Br J Dermatol 135(2):211–217PubMedCrossRef
16.
Zurück zum Zitat Paus R, Nickoloff BJ, Ito T (2005) A ‘hairy’ privilege. Trends Immunol 26:1CrossRef Paus R, Nickoloff BJ, Ito T (2005) A ‘hairy’ privilege. Trends Immunol 26:1CrossRef
17.
Zurück zum Zitat Price VH, Willey A, Chen BK (2005) Topical tacrolimus in alopecia areata. J Am Acad Dermatol 52(1):138–139PubMedCrossRef Price VH, Willey A, Chen BK (2005) Topical tacrolimus in alopecia areata. J Am Acad Dermatol 52(1):138–139PubMedCrossRef
18.
Zurück zum Zitat Shahin A (2005) Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol 26:5:6 Shahin A (2005) Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol 26:5:6
19.
Zurück zum Zitat Shapiro J (1993) Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin 11(3):611–617PubMed Shapiro J (1993) Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin 11(3):611–617PubMed
20.
Zurück zum Zitat van der Steen PH, Boezeman JB, Happle R (1992) Topical immunotherapy for alopecia areata: re-evaluation of 139 casesafter an additional follow-up period of 19 months. Dermatology 184(3):198–201PubMedCrossRef van der Steen PH, Boezeman JB, Happle R (1992) Topical immunotherapy for alopecia areata: re-evaluation of 139 casesafter an additional follow-up period of 19 months. Dermatology 184(3):198–201PubMedCrossRef
21.
Zurück zum Zitat Wiseman MC, Shapiro J, MacDonald N, Lui H (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137(8):1063–1068PubMed Wiseman MC, Shapiro J, MacDonald N, Lui H (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137(8):1063–1068PubMed
Metadaten
Titel
Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone
verfasst von
Tomasz Wasyłyszyn
Wojciech Kozłowski
Stanisław Leopold Zabielski
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 5-6/2007
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-007-0759-4

Weitere Artikel der Ausgabe 5-6/2007

Archives of Dermatological Research 5-6/2007 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.